All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
This disclosure generally relates to vapor generation in medical instruments. More specifically, this disclosure relates to induction coil vapor generators in medical instruments.
Benign prostatic hyperplasia (BPH) is a common disorder in middle-aged and older men, with prevalence increasing with age. At age 70, more than one-half of men have symptomatic BPH, and nearly 90% of men have microscopic evidence of an enlarged prostate. The severity of symptoms also increase with age with 27% of patients in the 60-70 age bracket having moderate-to-severe symptoms, and 37% of patients in their 70's suffering from moderate-to-severe symptoms.
The prostate early in life is the size and shape of a walnut and weighs about 20 grams. Prostate enlargement appears to be a normal process. With age, the prostate gradually increases in size to twice or more its normal size. The fibromuscular tissue of the outer prostatic capsule restricts expansion after the gland reaches a certain size. Because of such restriction on expansion, the intracapsular tissue will compress against and constrict the prostatic urethra thus causing resistance to urine flow.
BPH is typically diagnosed when the patient seeks medical treatment complaining of bothersome urinary difficulties. The predominant symptoms of BPH are an increase in frequency and urgency of urination. BPH can also cause urinary retention in the bladder which in turn can lead to lower urinary tract infection (LUTI). In many cases, the LUTI then can ascend into the kidneys and cause chronic pyelonephritis, and can eventually lead to renal insufficiency. BPH also may lead to sexual dysfunction related to sleep disturbance or psychological anxiety caused by severe urinary difficulties. Thus, BPH can significantly alter the quality of life with aging of the male population.
BPH is the result of an imbalance between the continuous production and natural death (apoptosis) of the glandular cells of the prostate. The overproduction of such cells leads to increased prostate size, most significantly in the transitional zone which traverses the prostatic urethra.
In early stage cases of BPH, treatments can alleviate the symptoms. For example, alpha-blockers treat BPH by relaxing smooth muscle tissue found in the prostate and the bladder neck, which may allow urine to flow out of the bladder more easily. Such drugs can prove effective until the glandular elements cause overwhelming cell growth in the prostate.
More advanced stages of BPH, however, can only be treated by surgical or minimally invasive tissue ablation interventions. A number of methods have been developed using electrosurgical or mechanical extraction of tissue, and thermal ablation of intracapsular prostatic tissue. In many cases, such interventions provide only transient relief, and there often is significant peri-operative discomfort and morbidity.
An inductive vapor generator is provided, comprising an outer support assembly, a coil disposed around the outer support assembly, an inner assembly disposed within the outer support assembly, a plurality of microtubes disposed within the inner assembly, the microtubes being configured to receive a fluid from a fluid source, and a RF generator electrically coupled to the coil, the RF generator being configured to apply a current to the coil to inductively heat fluid in the plurality of microtubes to convert the fluid into a heated condensable vapor.
In some embodiments, the outer support assembly comprises a thermally insulating and electrically insulating tube.
In other embodiments, the inner assembly comprises a thermally conductive and electrically insulating tube.
In some embodiments, the generator comprises an air gap between the outer support assembly and the inner assembly.
In one embodiment, the plurality of microtubes comprises stainless steel microtubes.
In some embodiments, the inner assembly comprises a solid metal rod and the plurality of microtubes comprises an array of channels drilled through the solid metal rod.
In one embodiment, the outer support assembly has a length of less than 70 mm.
In another embodiment, the outer support assembly has a diameter of less than 10 mm.
A medical vapor delivery device is also provided, comprising a handle, a working shaft coupled to the handle, an induction vapor generator disposed in the handle and fluidly coupled to a fluid source and the working shaft, the induction vapor generator comprising, an outer support assembly, a coil disposed around the outer support assembly, an inner assembly disposed within the outer support assembly, a plurality of microtubes disposed within the inner assembly, a RF generator electrically coupled to the coil, the RF generator configured to apply a current to the coil, and a controller configured to apply a current to the coil to convert a fluid in the plurality of microtubes into a heated vapor inside the induction vapor generator for delivery of the heated vapor through the working shaft to human tissue.
In some embodiments, the device further comprises a treatment needle disposed near a distal portion of the working shaft.
In some embodiments, the outer support assembly comprises a thermally insulating and electrically insulating tube.
In other embodiments, the inner assembly comprises a thermally conductive and electrically insulating tube.
In some embodiments, the generator comprises an air gap between the outer support assembly and the inner assembly.
In one embodiment, the plurality of microtubes comprises stainless steel microtubes.
In some embodiments, the inner assembly comprises a solid metal rod and the plurality of microtubes comprises an array of channels drilled through the solid metal rod.
In one embodiment, the outer support assembly has a length of less than 70 mm.
In another embodiment, the outer support assembly has a diameter of less than 10 mm.
A method of generating a heated condensable vapor is also provided, comprising injecting a fluid into a plurality of microtubes disposed within an inner tube assembly, applying a current to a coil that is supported by an outer tube assembly, the inner tube assembly being disposed within the outer tube assembly, and inductively heating the fluid within the plurality of microtubes to convert the fluid to a heated condensable vapor.
In some embodiments, the method further comprises insulating the coil from heat with a gap disposed between the inner tube assembly and the outer tube assembly. In one embodiment, the gap comprises an air gap.
The novel features of the invention are set forth with particularity in the claims that follow. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:
The present disclosure describes methods and apparatus for treating BPH, comprising introducing a heated vapor interstitially into the interior of a prostate, wherein the vapor controllably ablates prostate tissue. This method can utilize vapor for applied energy of between 100 calories and 1,000 calories per lobe in an office-based procedure. In some embodiments, the system includes a vapor delivery mechanism that generates and delivers high quality heated water vapor. The system can utilize a vapor source configured to provide vapor having a temperature of at least 60° C., 80° C., 100° C., 120° C., or 140° C. In some embodiments, the vapor source can comprise an induction coil vapor generator disposed within a vapor delivery device, or alternatively, located outside of the vapor delivery device.
In some embodiments, the outer assembly can comprise an electrically insulating and thermally insulating material, such as fiberglass, or low density silicone, and the inner assembly can comprise an electrically insulating, thermally conductive material, such as aluminum nitride, alloys of iron including stainless steels, alloys of nickel, alloys of cobalt, quartz, glass, or a ceramic such as aluminum oxide. The outer assembly can be thermally insulating to prevent heat from damaging the coiled magnet wire or from damaging human tissue or other medical device components positioned exterior to the outer assembly. The inner assembly and the microtubes can be thermally conductive so as to inductively heat fluid to convert the fluid into a condensable vapor.
The coiled magnet wire can comprise any electrically insulated wire, such as insulated copper, silver, gold or aluminum wire used in electromagnets (magnet wire or Litz wire), and can be coupled to a RF generator that produces a current in the coiled magnet wire to generate an inductive field. This inductive field can then be used to heat the inner assembly and/or microtubes to convert fluid in the microtubes into a heated condensable vapor. In one embodiment, the coiled magnet wire comprises 16 gauge copper coil, or magnet wire in the diameter range of 10 AWG to 20 AWG. In another embodiment, the outer assembly is wrapped in magnet wire having 16 AWG and approximately 30.5 turns. The length of the tubes and the gauge and number of wraps of the wire can be adjusted, however, depending on the application and the desired size of the generator, for example with coils in the range of 10 to 100 turns wound with wire in the range 10 to 20 AWG.
Referring back to
The microtubes 108 can be encased in inner assembly 106, with O-ring supported pressure-fit caps 110a and 110b sealing both ends of the inner assembly. Cap 110a can be disposed on a distal, vapor emitting end of the generator 100, and cap 110b can be disposed on a proximal, fluid source connecting end of the generator. Liquid water or fluid can flow into the inner assembly and microtubes from a remote fluid source, such as fluid source 118, and the fluid can be inductively heated and converted into condensable vapor when a current is applied to the coiled magnet wire 102 (such as by a RF generator). The parallel array of the microtubes 108 in the inner assembly allows laminar flow of the water/vapor, minimizing back pressure on the fluid source. Heat is transferred efficiently from the inside and outside surfaces of the heated microtubes to the fluid flowing through and between the microtubes because of the large ratio of heated surface area to fluid volume in the microtubes.
In one embodiment, the microtubes can be aligned in parallel with the length of the coiled magnet wire, thereby making them parallel to the inductive magnetic field that is generated when current is applied to the coil. When the tubes are aligned in this fashion, current flows around the circumference of the tubes maximizing the ability of each tube to be heated when an inductive magnetic field is created. As fluid enters the inner assembly and is converted to vapor, the fluid and vapor passes through and between the tubes, thereby contacting both their inner and outer surfaces during the super heating travel from one end of the assembly to the other.
In one embodiment, the idealized expansion ratio of a volume of liquid water converted to pure water vapor is 1760×. This liquid-to-vapor expansion introduces significant mechanical forces even at the small volumes utilized in the inductive vapor generator described above. The most notable mechanical force is back pressure on the fluid source that delivers fluid to the inner assembly and microtubes. Since vapor expansion in a container has no preferred direction, the vapor produced can push backwards as well as forward. The arrangement of the microtubes can minimize the adverse back pressure to allow a syringe pump of normal strength to be used. The microtubes promote laminar flow and also prevent a “core” of liquid water from slipping through the generator by increasing the amount of surface area the water is in contact with. Enhanced contact of the water with the tube surfaces may be achieved by roughening or patterning the tube surfaces to encourage turbulent flow of the water.
Referring still to
In an alternative embodiment, the coiled magnet wire 102 may be wound directly onto the inner assembly 106, placing the outer coil in direct thermal contact with the inner coil assembly. As long as water is being converted to steam in the inner coil assembly 106, the inner coil, and in this embodiment the outer coil, will be maintained at the boiling temperature of water during therapy delivery. Providing that the insulation of the coiled magnet wire or Litz wire of the outer coil can operate at the boiling temperature of water, this is an acceptable embodiment. Commonly used insulation materials can operate to at least 200° C., well above the boiling temperature of water, even at elevated pressures experienced within the heating element. This embodiment may insure repeatable temperatures during therapy and between therapy applications.
The inner assembly can further comprise a sintered filter 112, configured to mechanically aerosolize the fluid as it enters the inner assembly and also to impede backflow, and a spacer tube 114, configured to further increase the ratio of vapor to liquid water before the heated condensable vapor leaves the generator. The sintered filter can comprise a porous disc made of, for example, 316 stainless steel and including very small openings on the order of 10 microns. The spacer tube 114 can comprise a stainless steel tube and can be relatively short compared to the length of the tubes. For example, in one embodiment, the spacer tube is up to approximately 8.5 mm long or 10-15% of the length of the insulating tubes.
In some embodiments, the outer assembly 104 can have a length D1 ranging from 40 mm to 100 mm and a diameter ranging from 4 mm to 25 mm. The inner assembly 106 can have a length D2 ranging from 35 mm to 95 mm and a diameter ranging from 2 mm to 23 mm. The coiled magnet wire 102 can be wound along a length D5 of the outer assembly, ranging from the full length of the outer assembly to only the length of the microtubes 108 (microtube length illustrated by D4). D3 in
In one embodiment, the inner and outer assemblies can be fused quartz, having a low coefficient of thermal expansion, on the order of 0.55×10−8/° C., and a temperature strain point of approximately 1070° C. The quartz tubes have a high resistance to thermal shock, and relatively low thermal conductivity (approximately 0.0033 cal cm−1 sec−1° C. and low dielectric loss factor (<0.0004 at 20° C., 1 MHz). The quartz tubes also have a high tensile strength (approximately 7,000 psi) and a very high compressive strength (approximately 11.1×106 psi).
The inductive generators described herein can be designed to fit into a handheld vapor delivery device, and integrate with a controller 530, a fluid source 518, and a radiofrequency (RF) generator 528.
In some embodiments, the device 500 is configured for transurethral access to the prostate of the patient. When the distal end of the device is positioned in the prostatic urethra near the prostate, needle 532 can be advanced into the prostate, and vapor generated in the inductive vapor generator can be delivered to the prostate to treat the prostate tissue.
In other embodiments, the vapor generator can be disposed external to the device 500 and can be configured to deliver vapor to the device. A proximal portion of the vapor generator can be fluidly coupled to a fluid source. A distal portion of the vapor generator can be fluidly coupled to the delivery device.
Inductive heating provides fast, consistent heat and can be used in a variety of applications. Inductive heating occurs when an electrically conducting object is exposed to a rapidly changing magnetic field. This is caused by an outer component such as a coil, through which a large high frequency electric current flows. This outer component experiences minimal heating itself due to its low resistance. The passage of current through this coil generates a very intense and rapidly changing magnetic field in the space within the coil. The magnetic field generated by the coil is dependent on the coil current multiplied by the number of coil turns per unit length (ampere turns per meter).
The alternating magnetic field induces a current flow in the inner component, or the metal being heated. The arrangement of the coil and the inner component can be thought of as an electrical transformer, but one in which electrical power transfer is intended to be inefficient, changing the “wasted” electrical energy to heat energy. The coil is the primary winding receiving RF energy from the RF generator and the inner component is like a single turn secondary winding that is short-circuited. This causes high currents (called eddy currents) to flow through the inner component causing it to heat up.
In addition to this, the high frequency used for induction heating gives rise to a phenomenon called skin effect. This skin effect forces the induced alternating current to flow in a thin layer towards the surface of the inner component. The skin effect increases the effective resistance of the metal to the passage of the large current. Therefore it greatly increases the heating effect caused by the current induced in the workpiece. On the other hand, the skin effect may adversely increase the resistance of the coiled magnet wire 102.
For ferrous metals like iron and some steels, the magnetic permeability of the inner coil material can enhance or magnify the magnetic field generated by the coiled magnet wire 102, thereby increasing the magnitude of the eddy currents and inductive heating of the inner coil for a given current flowing in the outer coiled wire. There is an additional heating mechanism that takes place in ferromagnetic materials at the same time as the eddy currents mentioned above. These intense magnetic fields inside the coil repeatedly magnetize and de-magnetize the iron crystals. This rapid flipping of the magnetic domains causes considerable friction and heating inside the material. Heating due to this mechanism is known as Hysteresis loss. For these reasons, ferrous materials having magnetic properties lend themselves more easily to induction heating than those without magnetic properties.
Unlike direct resistive heating, the current coming directly from the power source never directly contacts the material being heated. Instead, it is transformed first to a magnetic field, then as that magnetic field affects the conduction in the inner component, back to a self-contained secondary electric circuit.
Direct resistive heating is also capable of making water vapor, in some applications. However, arcing and plating are inescapable by-products of using direct resistive heating and the consequences (deterioration of electrodes, etc.) create great difficulties in controlling such vapor for precision applications.
Several parameters must be balanced in an induction generator design to improve the quality of the vapor being generated. These parameters include, but are not limited to: magnet wire coil impedance, frequency of driving RF energy, composition of materials being heated, geometry of internal components, management of mechanical forces, and RF source impedance matching (including C-matching network).
Inductance in the coil can be increased by adding more turns to the wire coil, increasing the coil diameter, and shortening the length of the coil. However, increasing inductions via each of these examples may also come with some consequences. For example, adding more turns to the wire coil (where the coil maintains the same coil length) requires a thinner coil wire, which increases the resistive heating in the outer coil component. This is one of the consequences that the use of inductive heating is designed to prevent.
In one example of the coil in
A larger coil diameter causes the generator unit to increase in size, and reduces the magnetic coupling to the inner heated component which can cause efficiency reduction. If the inner heated component is made larger to compensate, the vapor inside this larger space must be reduced proportionally more to enter the treatment needle, which can cause turbulent flow. This also causes back pressure on the syringe pump delivering liquid water to be converted to vapor, and may even cause condensation.
Shortening the length of the assembly means a shorter length for the inner, heated component. As the ability to convert liquid water to vapor is directly proportional to the surface area of the heated inner component that the water can contact, and a shorter assembly of the same design will always have less surface area, a shorter assembly will be less able to completely and consistently create vapor.
In electronics, impedance matching is the practice of designing the input impedance of an electrical load or the output impedance of its corresponding signal source in order to maximize the power transfer and/or minimize reflections from the load. In the vapor generator described above, a higher frequency is advantageous since only the inductive microtubes need to be heated in order to convert liquid to vapor. A high frequency combined with a load resistance in the wire coil causes the impedance of the generator to become primarily reactive, which calls for complex conjugate mapping and C-matching.
In the generator above, the wire coil is made to resonate at the intended operating frequency by way of a capacitor placed in parallel with the coil. This parallel resonance recaptures the current exiting the coil, both preventing the current from being reflected against incoming current in the opposite direction during polarity shift and magnifying the current through the work coil compared to the output current capability of the RF generator alone. In this case, the RF generator only has to provide the part of the load current that actually does real work and is lost by converting electrical energy to heat, not the full circulating current in the coil.
The parallel resonant circuit can make a tenfold reduction in the current that must be supported by the RF generator and the wires connecting it to the coil. Conduction losses are typically proportional to current squared, so a tenfold reduction in load current represents a significant saving in conduction losses in the RF generator and associated wiring.
In a parallel resonant tank circuit the coil can be thought of as an inductive load with a power factor correction (“PFC”) capacitor connected across it. As connecting a capacitor would normally shift current and voltage 90 degrees out of phase to each other, the PFC capacitor is chosen with specifications to provide a reactive current flow equal and opposite to the large inductive current drawn by the coil. This cancels the phase shift effect and brings voltage and current back into phase for maximum power. Therefore, the only real current flow from the RF generator is the relatively small amount required to overcome losses in the PFC capacitor and coil.
Large eddy currents flowing on the surface of the induction tubes are required in order to heat the inductive microtubes. It is the job of the matching network and the coil itself to transfer a high voltage, low current from the RF generator to the low voltage, high current required to heat the induction tubes efficiently.
Referring to
In the case of a parallel resonant circuit, this loss resistance appears directly across the tank circuit. This resistance represents the only component that can consume real power, and therefore this can be considered as the load which power is being driven into in an efficient manner, as shown in
When driven at resonance, the current drawn by the tank capacitor and the work coil are equal in magnitude and opposite in phase and therefore cancel each other out as far as the source of power is concerned. This means that the only load seen by the RF generator at the resonant frequency is the loss resistance across the tank circuit. This loss resistance is quite low, however. The resistance of either the coil or capacitor alone would be low to begin with, and by being placed in parallel, the combined resistance is lowered even further. This places the combined load (coil and tank capacitor) even further away from the impedance for which the RF generator is optimized with its own impedance. For any RF generator attached to a real world load, the power delivered from the output terminal already has current and voltage out of phase, with the presumption that an operator will use a load closely matched to this RF generator impedance.
In the case of the vapor generator, the parallel resonant tank circuit is important, as it recirculates power that otherwise would exit the low impedance load and be reflected, but the low impedance of the combined load is even less matched to the generator, and recirculation of out-of-phase current and voltage takes them more out of phase.
The job of the C-matching network is to move delivered current and voltage back into phase and transform the relatively low loss resistance across the tank circuit up to a higher value that better suits the RF generator. This is as simple as placing the proper capacitor in series between the RF generator and coil.
Referring to
In the embodiments, described above, the generator is formed from outer and inner assemblies comprising hollow tubes. In an alternative embodiment, the generator can be constructed from a solid metal rod with holes drilled through the length of the rod, as shown in
Although particular embodiments of the present invention have been described above in detail, it will be understood that this description is merely for purposes of illustration and the above description of the invention is not exhaustive. Specific features of the invention are shown in some drawings and not in others, and this is for convenience only and any feature may be combined with another in accordance with the invention. A number of variations and alternatives will be apparent to one having ordinary skills in the art. Such alternatives and variations are intended to be included within the scope of the claims. Particular features that are presented in dependent claims can be combined and fall within the scope of the invention. The invention also encompasses embodiments as if dependent claims were alternatively written in a multiple dependent claim format with reference to other independent claims.
This Application claims the benefit of U.S. Provisional Patent Application No. 61/619,818, filed Apr. 3, 2012, titled “Induction Coil Vapor Generator”, which is incorporated by reference in its entirety.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2013/035144 | 4/3/2013 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2013/152119 | 10/10/2013 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
408899 | Small | Aug 1889 | A |
1719750 | Bridge et al. | Jul 1929 | A |
4672963 | Barken | Jun 1987 | A |
4920982 | Goldstein | May 1990 | A |
4950267 | Ishihara et al. | Aug 1990 | A |
5117482 | Hauber | May 1992 | A |
5222185 | McCord, Jr. | Jun 1993 | A |
5249585 | Turner et al. | Oct 1993 | A |
5300099 | Rudie | Apr 1994 | A |
5312399 | Hakky et al. | May 1994 | A |
5330518 | Neilson et al. | Jul 1994 | A |
5366490 | Edwards et al. | Nov 1994 | A |
5370609 | Drasler et al. | Dec 1994 | A |
5370675 | Edwards et al. | Dec 1994 | A |
5370677 | Rudie et al. | Dec 1994 | A |
5385544 | Edwards et al. | Jan 1995 | A |
5409453 | Lundquist et al. | Apr 1995 | A |
5413588 | Rudie et al. | May 1995 | A |
5421819 | Edwards et al. | Jun 1995 | A |
5435805 | Edwards et al. | Jul 1995 | A |
5464437 | Reid et al. | Nov 1995 | A |
5470308 | Edwards et al. | Nov 1995 | A |
5470309 | Edwards et al. | Nov 1995 | A |
5484400 | Edwards et al. | Jan 1996 | A |
5499998 | Meade | Mar 1996 | A |
5531676 | Edwards et al. | Jul 1996 | A |
5531763 | Mastri et al. | Jul 1996 | A |
5542915 | Edwards et al. | Aug 1996 | A |
5542916 | Hirsch et al. | Aug 1996 | A |
5545171 | Sharkey et al. | Aug 1996 | A |
5549644 | Lundquist et al. | Aug 1996 | A |
5554110 | Edwards et al. | Sep 1996 | A |
5556377 | Rosen et al. | Sep 1996 | A |
5558673 | Edwards et al. | Sep 1996 | A |
5588960 | Edwards et al. | Dec 1996 | A |
5591125 | Edwards et al. | Jan 1997 | A |
5599294 | Edwards et al. | Feb 1997 | A |
5601591 | Edwards et al. | Feb 1997 | A |
5628770 | Thome et al. | May 1997 | A |
5630794 | Lax et al. | May 1997 | A |
5645528 | Thome | Jul 1997 | A |
5667488 | Lundquist et al. | Sep 1997 | A |
5672153 | Lax et al. | Sep 1997 | A |
5709680 | Yates et al. | Jan 1998 | A |
5720718 | Rosen et al. | Feb 1998 | A |
5720719 | Edwards et al. | Feb 1998 | A |
5776176 | Rudie | Jul 1998 | A |
5792070 | Kauphusman et al. | Aug 1998 | A |
5797903 | Swanson et al. | Aug 1998 | A |
5800486 | Thome et al. | Sep 1998 | A |
5807395 | Mulier et al. | Sep 1998 | A |
5830179 | Mikus et al. | Nov 1998 | A |
5843144 | Rudie et al. | Dec 1998 | A |
5849011 | Jones et al. | Dec 1998 | A |
5861021 | Thome et al. | Jan 1999 | A |
5871481 | Kannenberg et al. | Feb 1999 | A |
5873877 | McGaffigan et al. | Feb 1999 | A |
5897553 | Mulier et al. | Apr 1999 | A |
5899932 | Dann et al. | May 1999 | A |
5938692 | Rudie | Aug 1999 | A |
5944715 | Goble et al. | Aug 1999 | A |
5951515 | Osterlind | Sep 1999 | A |
5957922 | Imran | Sep 1999 | A |
5964752 | Stone | Oct 1999 | A |
5964756 | McGaffigan et al. | Oct 1999 | A |
5976123 | Baumgardner et al. | Nov 1999 | A |
5987360 | McGrath et al. | Nov 1999 | A |
5990465 | Nakaoka et al. | Nov 1999 | A |
6007571 | Neilson et al. | Dec 1999 | A |
6009351 | Flachman | Dec 1999 | A |
6017358 | Yoon et al. | Jan 2000 | A |
6017361 | Mikus et al. | Jan 2000 | A |
6036631 | McGrath et al. | Mar 2000 | A |
6036713 | Kieturakis | Mar 2000 | A |
6053909 | Shadduck | Apr 2000 | A |
6063081 | Mulier et al. | May 2000 | A |
6067475 | Graves et al. | May 2000 | A |
6077257 | Edwards et al. | Jun 2000 | A |
6113593 | Tu et al. | Sep 2000 | A |
6122551 | Rudie et al. | Sep 2000 | A |
6123083 | McGrath et al. | Sep 2000 | A |
6147336 | Oshijima et al. | Nov 2000 | A |
6148236 | Dann | Nov 2000 | A |
6156036 | Sussman et al. | Dec 2000 | A |
6161049 | Rudie et al. | Dec 2000 | A |
6179805 | Sussman et al. | Jan 2001 | B1 |
6179836 | Eggers et al. | Jan 2001 | B1 |
6206847 | Edwards et al. | Mar 2001 | B1 |
6210404 | Shadduck | Apr 2001 | B1 |
6223085 | Dann et al. | Apr 2001 | B1 |
6231591 | Desai | May 2001 | B1 |
6238389 | Paddock et al. | May 2001 | B1 |
6238391 | Olsen et al. | May 2001 | B1 |
6238393 | Mulier et al. | May 2001 | B1 |
6241702 | Lundquist et al. | Jun 2001 | B1 |
6258087 | Edwards et al. | Jul 2001 | B1 |
6272384 | Simon et al. | Aug 2001 | B1 |
6287297 | Woodruff et al. | Sep 2001 | B1 |
6302903 | Mulier et al. | Oct 2001 | B1 |
6312391 | Ramadhyani et al. | Nov 2001 | B1 |
6315777 | Comben | Nov 2001 | B1 |
6348039 | Flachman et al. | Feb 2002 | B1 |
6398759 | Sussman et al. | Jun 2002 | B1 |
6409722 | Hoey et al. | Jun 2002 | B1 |
6423027 | Gonon | Jul 2002 | B1 |
6440127 | McGovern et al. | Aug 2002 | B2 |
6461296 | Desai | Oct 2002 | B1 |
6494902 | Hoey et al. | Dec 2002 | B2 |
6496737 | Rudie et al. | Dec 2002 | B2 |
6508816 | Shadduck | Jan 2003 | B2 |
6517534 | McGovern et al. | Feb 2003 | B1 |
6524270 | Bolmsjo et al. | Feb 2003 | B1 |
6537248 | Mulier et al. | Mar 2003 | B2 |
6537272 | Christopherson et al. | Mar 2003 | B2 |
6544211 | Andrew et al. | Apr 2003 | B1 |
6551300 | McGaffigan | Apr 2003 | B1 |
6565561 | Goble et al. | May 2003 | B1 |
6575929 | Sussman et al. | Jun 2003 | B2 |
6575968 | Eggers et al. | Jun 2003 | B1 |
6579270 | Sussman et al. | Jun 2003 | B2 |
6589201 | Sussman et al. | Jul 2003 | B1 |
6607529 | Jones et al. | Aug 2003 | B1 |
6638275 | McGaffigan et al. | Oct 2003 | B1 |
6640139 | Ueberle | Oct 2003 | B1 |
6669694 | Shadduck | Dec 2003 | B2 |
6676628 | Sussman et al. | Jan 2004 | B2 |
6706039 | Mulier et al. | Mar 2004 | B2 |
6716252 | Lazarovitz et al. | Apr 2004 | B2 |
6719738 | Mehier | Apr 2004 | B2 |
6726696 | Houser et al. | Apr 2004 | B1 |
6730079 | Lovewell | May 2004 | B2 |
6736810 | Hoey et al. | May 2004 | B2 |
6740108 | Just et al. | May 2004 | B1 |
6760616 | Hoey et al. | Jul 2004 | B2 |
6780178 | Palanker et al. | Aug 2004 | B2 |
6827718 | Hutchins et al. | Dec 2004 | B2 |
6855141 | Lovewell | Feb 2005 | B2 |
6887237 | McGaffigan | May 2005 | B2 |
6905475 | Hauschild et al. | Jun 2005 | B2 |
6911028 | Shadduck | Jun 2005 | B2 |
6969376 | Takagi et al. | Nov 2005 | B2 |
6974455 | Garabedian et al. | Dec 2005 | B2 |
7014652 | Cioanta et al. | Mar 2006 | B2 |
7041121 | Williams et al. | May 2006 | B1 |
7066935 | Swoyer et al. | Jun 2006 | B2 |
7089064 | Manker et al. | Aug 2006 | B2 |
7130697 | Chornenky et al. | Oct 2006 | B2 |
7238182 | Swoyer et al. | Jul 2007 | B2 |
7247155 | Hoey et al. | Jul 2007 | B2 |
7261709 | Swoyer et al. | Aug 2007 | B2 |
7261710 | Elmouelhi et al. | Aug 2007 | B2 |
7322974 | Swoyer et al. | Jan 2008 | B2 |
7328068 | Spinelli et al. | Feb 2008 | B2 |
7328069 | Gerber | Feb 2008 | B2 |
7335197 | Sage et al. | Feb 2008 | B2 |
7340300 | Christopherson et al. | Mar 2008 | B2 |
7369894 | Gerber | May 2008 | B2 |
7429262 | Woloszko et al. | Sep 2008 | B2 |
7437194 | Skwarek et al. | Oct 2008 | B2 |
7470228 | Connors et al. | Dec 2008 | B2 |
7549987 | Shadduck | Jun 2009 | B2 |
7865250 | Mrva et al. | Jan 2011 | B2 |
7894913 | Boggs et al. | Feb 2011 | B2 |
7959577 | Schmitz et al. | Jun 2011 | B2 |
8048069 | Skwarek et al. | Nov 2011 | B2 |
8216217 | Sharkey et al. | Jul 2012 | B2 |
8244327 | Fichtinger et al. | Aug 2012 | B2 |
8251985 | Hoey et al. | Aug 2012 | B2 |
8272383 | Hoey et al. | Sep 2012 | B2 |
8273079 | Hoey et al. | Sep 2012 | B2 |
8301264 | Achenbach et al. | Oct 2012 | B2 |
8313485 | Shadduck | Nov 2012 | B2 |
8372065 | Hoey et al. | Feb 2013 | B2 |
8388611 | Shadduck et al. | Mar 2013 | B2 |
8409109 | Tiesma et al. | Apr 2013 | B2 |
8419723 | Shadduck et al. | Apr 2013 | B2 |
8550743 | Bonde et al. | Oct 2013 | B2 |
8585692 | Shadduck et al. | Nov 2013 | B2 |
8632530 | Hoey et al. | Jan 2014 | B2 |
8740957 | Masotti | Jun 2014 | B2 |
8801702 | Hoey et al. | Aug 2014 | B2 |
8900223 | Shadduck | Dec 2014 | B2 |
20020062123 | McClurken | May 2002 | A1 |
20020078956 | Sharpe et al. | Jun 2002 | A1 |
20020111617 | Cosman et al. | Aug 2002 | A1 |
20020177846 | Mulier et al. | Nov 2002 | A1 |
20030069575 | Chin et al. | Apr 2003 | A1 |
20030092689 | Escandon et al. | May 2003 | A1 |
20030097126 | Woloszko et al. | May 2003 | A1 |
20030130575 | Desai | Jul 2003 | A1 |
20030206730 | Golan | Nov 2003 | A1 |
20040006334 | Beyar et al. | Jan 2004 | A1 |
20040068306 | Shadduck | Apr 2004 | A1 |
20040186422 | Rioux et al. | Sep 2004 | A1 |
20040230316 | Cioanta et al. | Nov 2004 | A1 |
20040267340 | Cioanta et al. | Dec 2004 | A1 |
20050096629 | Gerber et al. | May 2005 | A1 |
20050124915 | Eggers et al. | Jun 2005 | A1 |
20050149020 | Jahng | Jul 2005 | A1 |
20050159676 | Taylor et al. | Jul 2005 | A1 |
20060089636 | Christopherson et al. | Apr 2006 | A1 |
20060135955 | Shadduck | Jun 2006 | A1 |
20060178670 | Woloszko et al. | Aug 2006 | A1 |
20060224154 | Shadduck et al. | Oct 2006 | A1 |
20060224169 | Weisenburgh, II et al. | Oct 2006 | A1 |
20060253069 | Li et al. | Nov 2006 | A1 |
20060276871 | Lamson et al. | Dec 2006 | A1 |
20070032785 | Diederich et al. | Feb 2007 | A1 |
20070038089 | Hatano et al. | Feb 2007 | A1 |
20070142846 | Catanese, III et al. | Jun 2007 | A1 |
20070179491 | Kratoska et al. | Aug 2007 | A1 |
20070197864 | Dejima et al. | Aug 2007 | A1 |
20070213703 | Naam et al. | Sep 2007 | A1 |
20080021484 | Catanese, III et al. | Jan 2008 | A1 |
20080021485 | Catanese, III et al. | Jan 2008 | A1 |
20080033232 | Catanese, III et al. | Feb 2008 | A1 |
20080033458 | McLean et al. | Feb 2008 | A1 |
20080033488 | Catanese, III et al. | Feb 2008 | A1 |
20080039833 | Catanese, III et al. | Feb 2008 | A1 |
20080039872 | Catanese, III et al. | Feb 2008 | A1 |
20080039874 | Catanese, III et al. | Feb 2008 | A1 |
20080039875 | Catanese, III et al. | Feb 2008 | A1 |
20080039876 | Catanese, III et al. | Feb 2008 | A1 |
20080039893 | McLean et al. | Feb 2008 | A1 |
20080039894 | Catanese, III et al. | Feb 2008 | A1 |
20080046045 | Yon et al. | Feb 2008 | A1 |
20080110457 | Barry et al. | May 2008 | A1 |
20080132826 | Shadduck et al. | Jun 2008 | A1 |
20080188811 | Kim | Aug 2008 | A1 |
20080208187 | Bhushan et al. | Aug 2008 | A1 |
20080214956 | Briggs et al. | Sep 2008 | A1 |
20080217325 | Von Buren et al. | Sep 2008 | A1 |
20080249399 | Appling et al. | Oct 2008 | A1 |
20080262491 | Swoyer et al. | Oct 2008 | A1 |
20080269737 | Elmouelhi et al. | Oct 2008 | A1 |
20080269862 | Elmouelhi et al. | Oct 2008 | A1 |
20080275440 | Kratoska et al. | Nov 2008 | A1 |
20080297287 | Shachar et al. | Dec 2008 | A1 |
20080312497 | Elmouelhi et al. | Dec 2008 | A1 |
20090018553 | McLean et al. | Jan 2009 | A1 |
20090054871 | Sharkey et al. | Feb 2009 | A1 |
20090118722 | Ebbers | May 2009 | A1 |
20090138001 | Barry et al. | May 2009 | A1 |
20090149846 | Hoey | Jun 2009 | A1 |
20090199855 | Davenport | Aug 2009 | A1 |
20090216220 | Hoey et al. | Aug 2009 | A1 |
20090227998 | Aljuri et al. | Sep 2009 | A1 |
20090306640 | Glaze et al. | Dec 2009 | A1 |
20100016757 | Greenburg et al. | Jan 2010 | A1 |
20100049031 | Fruland et al. | Feb 2010 | A1 |
20100094270 | Sharma | Apr 2010 | A1 |
20100114083 | Sharma | May 2010 | A1 |
20100179416 | Hoey et al. | Jul 2010 | A1 |
20100193568 | Scheib et al. | Aug 2010 | A1 |
20100204688 | Hoey et al. | Aug 2010 | A1 |
20100256636 | Fernandez et al. | Oct 2010 | A1 |
20100262133 | Hoey et al. | Oct 2010 | A1 |
20100262137 | Nye et al. | Oct 2010 | A1 |
20100286679 | Hoey et al. | Nov 2010 | A1 |
20100292767 | Hoey et al. | Nov 2010 | A1 |
20100298948 | Hoey et al. | Nov 2010 | A1 |
20110060328 | Skwarek et al. | Mar 2011 | A1 |
20110077628 | Hoey et al. | Mar 2011 | A1 |
20110106072 | Sundquist et al. | May 2011 | A1 |
20110160648 | Hoey | Jun 2011 | A1 |
20110264176 | Jackson et al. | Oct 2011 | A1 |
20110319759 | Liu et al. | Dec 2011 | A1 |
20120259271 | Shadduck et al. | Oct 2012 | A1 |
20120265276 | Curley | Oct 2012 | A1 |
20120323167 | Hoey et al. | Dec 2012 | A1 |
20130006231 | Sharma et al. | Jan 2013 | A1 |
20130066308 | Landman | Mar 2013 | A1 |
20130072855 | Sherry et al. | Mar 2013 | A1 |
20130074847 | Hoey et al. | Mar 2013 | A1 |
20130172867 | Shadduck et al. | Jul 2013 | A1 |
20130261692 | Cardinal et al. | Oct 2013 | A1 |
20140039356 | Sachs et al. | Feb 2014 | A1 |
20140107637 | Hoey et al. | Apr 2014 | A1 |
20140200568 | Sharma | Jul 2014 | A1 |
20140288543 | Hoey et al. | Sep 2014 | A1 |
20150126990 | Sharma et al. | May 2015 | A1 |
20150157384 | Hoey et al. | Jun 2015 | A1 |
20160081736 | Hoey et al. | Mar 2016 | A1 |
20170056089 | Hoey et al. | Mar 2017 | A1 |
Number | Date | Country |
---|---|---|
2061443 | Sep 1990 | CN |
2418844 | Feb 2001 | CN |
101072544 | Nov 2007 | CN |
101257855 | Sep 2008 | CN |
101006939 | Nov 2008 | CN |
101491458 | Jul 2009 | CN |
101803947 | Aug 2010 | CN |
7-507696 | Aug 1995 | JP |
8-501957 | Mar 1996 | JP |
8-504613 | May 1996 | JP |
11-318925 | Nov 1999 | JP |
200014663 | Jan 2000 | JP |
2000005191 | Jan 2000 | JP |
2001500763 | Jan 2001 | JP |
2005137916 | Jun 2005 | JP |
WO 9210142 | Jun 1992 | WO |
WO 0124715 | Apr 2001 | WO |
WO 03088851 | Oct 2003 | WO |
WO 03096871 | Nov 2003 | WO |
WO 2006004482 | Jan 2006 | WO |
WO 2008083407 | Jul 2008 | WO |
WO2010080467 | Jul 2010 | WO |
WO2013160772 | Oct 2013 | WO |
WO2015089190 | Jun 2015 | WO |
Entry |
---|
US 5,326,343 A, 07/1994, Rudie et al. (withdrawn) |
Hastings et al.; U.S. Appl. No. 15/011,005 entitled “Vapor ablation systems and methods,” filed Jan. 29, 2016. |
Hastings et al.; U.S. Appl. No. 15/035,944 entitled “Vapor ablation systems and methods,” filed May 11, 2016. |
Hoey et al.; U.S. Appl. No. 15/154,536 entitled “Systems and methods for treating the bladder with condensable vapor,” filed May 13, 2016. |
Hoey et al.; U.S. Appl. No. 14/453,254 entitled “Systems and Methods for Treatment of BPH,” filed Aug. 6, 2014. |
HAI; Photoselective Vaporization Prostatectomy: A Palliative Treatment Option for Men with Urinary Obstruction Secondary to Prostate Cancer; PCRI Prost.Cancer Rsrch.lnst. Reprint.from PCRI Insights Nov. 2005, vol. 8(4); Dwnld from http://www.prostate-cancer.org/pcricms/node/233 on May 10, 2012; 4 pages. |
Nguyen et al; Updated results of magnetic resonance imaging guided partial prostate brachytherapy for favorable risk prostate cancer: implications for focal therapy; J. Urol.; 188(4); pp. 1151-1156; Oct. 2012. |
Hoey et al.; U.S. Appl. No. 14/773,853 entitled “Systems and methods for treating prostate cancer,” filed Sep. 9, 2015. |
Number | Date | Country | |
---|---|---|---|
20150025515 A1 | Jan 2015 | US |
Number | Date | Country | |
---|---|---|---|
61619818 | Apr 2012 | US |